Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment.
dc.contributor.affiliation | Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, United Kingdom. | |
dc.contributor.affiliation | Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America. | |
dc.contributor.affiliation | Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia. | |
dc.contributor.affiliation | Department of Life Sciences, Santa Cruz do Sul University, Santa Cruz do Sul, Brazil. | |
dc.contributor.affiliation | Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America. | |
dc.contributor.affiliation | Instituto Regional de Investigación en Salud, Caaguazú, Paraguay. | |
dc.contributor.affiliation | Ministry of Health, Health and Environmental Surveillance Secretariat, General Coordination for Tuberculosis, Endemic Mycoses and Non-Tuberculous Mycobacteria Surveillance, Brasília, (DF) Brazil. | |
dc.contributor.affiliation | Oswaldo Cruz Foundation, Campo Grande, Brazil. | |
dc.contributor.affiliation | Implementation Division, The Aurum Institute, Johannesburg, South Africa. | |
dc.contributor.affiliation | National Tuberculosis Control Program, Ministry of Public Health and Social Welfare (MSPyBS), Asunción, Paraguay. | |
dc.contributor.affiliation | ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. | |
dc.contributor.affiliation | Wits School of Public Health, Johannesburg, South Africa. | |
dc.contributor.affiliation | Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada. | |
dc.contributor.affiliation | Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. | |
dc.contributor.affiliation | School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil. | |
dc.contributor.affiliation | Manhiça Health Research Center, Maputo, Mozambique. | |
dc.contributor.affiliation | Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, United States of America. | |
dc.contributor.affiliation | London School of Hygiene and Tropical Medicine, London, United Kingdom. | |
dc.contributor.affiliation | Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain. | |
dc.contributor.affiliation | Research Department, School of Medicine, Universidad Pontificia Bolivariana, Medellin, Colombia. | |
dc.contributor.affiliation | Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, United States of America. | |
dc.contributor.affiliation | Department of Public Health, Facultad de Ciencias Médicas, Universidad Nacional de Asunción, Asunción, Paraguay. | |
dc.contributor.author | Narayan A | |
dc.contributor.author | Salindri AD | |
dc.contributor.author | Keshavjee S | |
dc.contributor.author | Muyoyeta M | |
dc.contributor.author | Velen K | |
dc.contributor.author | Rueda ZV | |
dc.contributor.author | Croda J | |
dc.contributor.author | Charalambous S | |
dc.contributor.author | García-Basteiro AL | |
dc.contributor.author | Shenoi SV | |
dc.contributor.author | Gonçalves CCM | |
dc.contributor.author | Ferreira da Silva L | |
dc.contributor.author | Possuelo LG | |
dc.contributor.author | Aguirre S | |
dc.contributor.author | Estigarribia G | |
dc.contributor.author | Sequera G | |
dc.contributor.author | Grandjean L | |
dc.contributor.author | Telisinghe L | |
dc.contributor.author | Herce ME | |
dc.contributor.author | Dockhorn F | |
dc.contributor.author | Altice FL | |
dc.contributor.author | Andrews JR | |
dc.date.accessioned | 2025-05-23T11:40:32Z | |
dc.date.issued | 2023-Oct | |
dc.description.abstract | In this Policy Forum piece, Aditya Narayan and colleagues discuss the challenges and opportunities for tuberculosis preventive treatment in carceral settings. | |
dc.identifier.doi | 10.1371/journal.pmed.1004288 | |
dc.identifier.uri | https://pubs.cidrz.org/handle/123456789/10211 | |
dc.source | PLoS medicine | |
dc.title | Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment. |